|
|||||
|
|
Risk of clinically relevant hypoglycaemia in patients with type 2 diabetes self-titrating insulin glargine U-100 |
|
| Authors: | Priscilla A. Hollander MD Jacek Kiljanski MD Erik Spaepen MSc Cynthia J. Harris PhD |
| Affiliation: | 1. Department of Endocrinology, Baylor Endocrine Center, Dallas, Texas;2. Department of Diabetes, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana;3. Department of Statistics, Eli Lilly Deutschland GmbH, Bad Homburg, Germany |
| Abstract: | |
| Keywords: | hypoglycaemia insulin glargine self-titration |